Standout Papers

Potent inhibition of DOT1L as treatment of MLL-fusion leukemia 2013 2026 2017 2021 539
  1. Potent inhibition of DOT1L as treatment of MLL-fusion leukemia (2013)
    Scott R. Daigle, Edward J. Olhava et al. Blood
  2. Ivosidenib and Azacitidine in IDH1 -Mutated Acute Myeloid Leukemia (2022)
    Pau Montesinos, Christian Récher et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 9 from Science/Nature 56 standout
Sub-graph 1 of 22

Citing Papers

The Cation−π Interaction in Chemistry and Biology
2025 Standout
Catalytic Asymmetric Synthesis of Chiral Caged Hydrocarbons as Arenes Bioisosteres
2025 Standout
2 intermediate papers

Works of Scott R. Daigle being referenced

Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
2013 Standout
Conformational Adaptation Drives Potent, Selective and Durable Inhibition of the Human Protein Methyltransferase DOT1L
2012

Author Peers

Author Last Decade Papers Cites
Scott R. Daigle 1563 759 133 257 44 1.9k
Giovanni Roti 796 559 209 298 56 1.4k
Oliver Galm 1456 596 224 429 51 1.9k
Frank Breitenbuecher 720 805 390 276 33 1.5k
F Viguié 849 829 271 295 45 1.6k
Shinichi Mizuno 1040 690 204 402 44 1.8k
Björn Hackanson 1229 573 178 336 50 1.7k
Claire Seedhouse 1107 544 157 541 62 1.7k
Andrew G. Muntean 1718 701 178 159 36 2.1k
Christine M. McMahon 1034 575 246 309 57 1.8k
Lara Tickenbrock 1002 706 326 224 27 1.5k

All Works

Loading papers...

Rankless by CCL
2026